Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conferences:

Conference Years:

Days Within Meeting:

Has CME:

Do I Have Access?

Access:

Availability:

Participation Type:

Categories:

Browse by: Sort by:
<< first | < prev page: of 14 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 11 12 13 14 presentations: 1 to 25 of 339
Glucocorticoid Signaling in the Fetal and Neonatal Brain
Donald DeFranco, PhD
University of Pittsburgh School of Medicine, Pittsburgh, PA
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Tale of Two Steroids: DHEA and DHEAS
Margaret Zacharin, DMedSci, FRACP
Royal Children's Hospital, Parkville, Australia
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Novel Therapeutic Approaches in the Management of Adrenal Insufficiency
Ashwini Mallappa, MD, MHSc
National Institutes of Health, Bethesda, MD
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Biochemical Twists in the Evaluation of a Patient With Pheochromocytoma
Karel Pacak, MD, PhD, DSc
National Institutes of Health, Bethesda, MD
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
New Challenges in Nuclear Imaging and Treatment of Pheochromocytoma: Too Many Members on Board?
Henri Timmers, MD, PhD
Radboud University Medical Centre, Nijmegen, Netherlands
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
The Achilles’ Heel in Genetic Testing of Pheochromocytoma
Mercedes Robledo, PhD
Centro Nacional de Investigaciones Oncológicas, Madrid, Spain
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Pituitary Gene Mutations and Cushing Disease
Gunter Stalla, MD
Medicover Neuroendocrinology, University of Munich, Munich, Germany
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Adrenal Somatic Gene Mutations Causing Cortisol Excess
Guido Di Dalmazi, MD
University of Bologna, Bologna, Italy
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Inherited Gene Mutations Causing Primary Macronodular Adrenal Hyperplasia in Familial Cushing’s Syndrome
Maria Fragoso, MD, PhD
Hospital Das Clinicas, University of Sao Paulo, Sao Paulo,, Brazil
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Mild Cushing’s Syndrome: Does It Matter?
Danae Delivanis, MD, PhD
Private Practice, Patras, Greece
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Treatment of Bilateral Adrenal Macronodular Hyperplasia
Jerome Bertherat, MD, PhD
Hopital Cochin, Paris, France
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Focus on Cortisol Excess in Primary Aldosteronism
Adina Turcu, MD, MS
University of Michigan Medical School, Ann Arbor, MI
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
One Size Doesn't Fit All: How Direct and Indirect Mineralocorticoid Actions Control Distal Nephron Sodium Transport
David Ellison, MD
Oregon Health and Science University, Portland, OR
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Glucocorticoid Metabolism in Salt-Induced Hypertension
Matthew Bailey, PhD, FRSB
The University of Edinburgh, Edinburgh, United Kingdom
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Mechanisms of Fructose-Mediated Hypertension: Sodium, RAS and Sympathetic Regulation
Noreen Rossi, MD
Wayne State University, Detroit, MI
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Chair
Maria-Christina Zennaro, MD, PhD
Inserm, Paris, France
Chair
Adina Turcu, MD
University of Michigan Medical School, Ann Arbor, MI
Welcome and Introductions
Aldosterone and Cardiometabolic Disease in African Americans
Joshua Joseph, MD
Ohio State University College of Medicine, Columbus, OH
Live Moderated Q&A
Genetic Advances in Familial and Sporadic Primary Aldosteronism and Their Potential Clinical Implications
Isabelle Bourdeau, MD
Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada
Live Moderated Q&A
New Mechanisms in the Pathophysiology of Primary Aldosteronism
Tracy Williams, PhD
University of Turin, Torino, Italy
Live Moderated Q&A and Session Closing
from ENDO 2021 on March 20, 2021 12:30 PM-2:00 PM
Meet the Professor
David Torpy, MBBS, PhD, FRACP
Royal Adelaide Hospital, Adelaide, Australia
from ENDO 2021 on March 20, 2021 2:00 PM-2:30 PM
Chair
Katja Kiseljak-Vassiliades, DO
University of Colorado Denver, Aurora, CO
Results of the ADIUVO Study, the First Randomized Trial on Adjuvant Mitotane in Adrenocortical Carcinoma Patients
Massimo Terzolo, MD
University of Turin San Luigi Hospital, Orbassano, Italy
Audience Q&A
Modified GRAS Score for Prognostic Classification of Adrenocortical Carcinoma: An ENSAT Multicentre Study
Yasir Elhassan, MD
University of Birmingham, Birmingham, United Kingdom
Audience Q&A
Biochemical Tumor Marker Status and Its Role in Treatment Response in Patients Who Received High-Specific-Activity I-131 MIBG in Advanced Pheochromocytoma and Paraganglioma (PPGL): Results From a Pivotal Phase 2 Clinical Trial
Camilo Jimenez, MD
UT MD Anderson Cancer Center, Houston, TX
Audience Q&A
Mortality and Specific Causes of Death in Endogenous Cushing’s Syndrome: A Systematic Review, Meta-Analysis and Meta-Regression
Padiporn Limumpornpetch, Endocrinologist
University of Leeds, Leeds, United Kingdom
Audience Q&A
from ENDO 2021 on March 20, 2021 2:15 PM-3:15 PM
Moderator
Maria-Christina Zennaro, MD, PhD
INSERM, Paris, France
Faculty
Ashley Grossman, MD, FRCP
Churchill Hospital, University of Oxford, Centre for Endocrinology, Barts and the London School of Medicine, University of London, London, United Kingdom
Case Presentation
Live Moderated Q&A
Case Presentation
Live Moderated Q&A and Session Closing
from ENDO 2021 on March 20, 2021 3:30 PM-4:15 PM
Moderator
Lauren Fishbein, MD, PhD
University of Colorado School of Medicine, Aurora, CO
Faculty
Richard Auchus, MD, PhD
University of Michigan Medical School, Ann Arbor, MI
Faculty
Irina Bancos, MD
Mayo Clinic, Rochester, MN
Case Presentation
Live Moderated Q&A
Case Presentation
Live Moderated Q&A and Session Closing
from ENDO 2021 on March 21, 2021 11:00 AM-11:45 AM
Moderator
Katherine Nathanson, MD
University of Pennsylvania, Philadelphia, PA
Panelist
Scott Akker, MBBS, PhD, MRCP
St. Bartholomew's Hospital, London, United Kingdom
Panelist
Roderick Clifton-Bligh, MBBS, PhD, FRACP
Royal North Shore Hospital, Sydney, Australia
Panelist
Karel Pacak, MD, PhD, DSc
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD
from ENDO 2021 on March 21, 2021 12:15 PM-1:45 PM
Chair
Wiebke Arlt, MD DSc FRCP FMedSci
University of Birmingham, Birmingham, United Kingdom
Effects of CRN04894, a Nonpeptide Orally Bioavailable ACTH Antagonist, on Corticosterone in Rodent Models of ACTH Excess
Melissa Fowler, PhD
Crinetics Pharmaceuticals, San Diego, CA
Audience Q&A
Insights From Targeted Genetic Analysis of 364 Adrenocortical Carcinomas
Katja Kiseljak-Vassiliades, DO
University of Colorado School of Medicine, Aurora, CO
Audience Q&A
Novel Germline SUCLG2 Mutations in Patients With Pheochromocytoma and Paraganglioma
Katerina Hadrava Vanova, Ph.D.
Eunice Kennedy Shriver National Institute of Child and Human Development, National Institutes of Health, Bethesda, MD
Audience Q&A
Genome-Wide Association Study Links Autoimmune Addison’s Disease to Break of Central Tolerance
Maribel Aranda Guillen, MSc
Karolinska Institutet, Stockholm, Sweden
Audience Q&A
from ENDO 2021 on March 21, 2021 2:00 PM-3:00 PM
Chair
Emilia Pinto, PhD
St. Jude Children's Research Hospital, Memphis, TN
Chair
Enzo Lalli, MD
Institut de Pharmacologie Moleculaire et Cellulaire, Valbonne, France
Welcome and Introductions
Metabolomics of Adrenocortical Carcinoma
Vasileios Chortis, MD, PhD
University of Birmingham, Birmingham, United Kingdom
Live Moderated Q&A
Histopathologic Markers of Aggressive Pheochromocytoma/Paraganglioma
Virginia LiVolsi, MD
University of Pennsylvania Hospital, Philadelphia, PA
Live Moderated Q&A
Molecular Classification for Prognosis in Adrenocortical Carcinoma
Guillaume Assié, MD, PhD
Paris Descartes University, Paris, France
Live Moderated Q&A and Session Closing
from ENDO 2021 on March 21, 2021 3:15 PM-4:45 PM
Moderator
Felix Beuschlein, MD
University Hospital Zurich, Zurich, Switzerland
Faculty
William Young, MD, MSc
Mayo Clinic, Rochester, MN
Case Presentation
Live Moderated Q&A
Case Presentation
Live Moderated Q&A and Session Closing
from ENDO 2021 on March 22, 2021 11:00 AM-11:45 AM
Chair
Maria Fleseriu, MD
Oregon Health and Science University, Portland, OR
Chair
John Wass, MA, MD, FRCP
Churchill Hospital, Oxford, United Kingdom
Welcome and Introductions
Cardiovascular Health and Acromegaly
Moises Mercado, MD
UIM en Enfermedades Endocrinasl, Hospital de Especialidades, Centro Mdico Nacional S.XXI and Centro d, Mexico City, Mexico
Live Moderated Q&A
Cardiovascular Health and Cushing's
Elena Valassi, MD, PhD
Hospital Sant Pau and Hospital Universitari General de Catalunya, Universitat Internacional de Catalunya (UIC), Barcelona, Spain
Live Moderated Q&A
Cardiovascular Risk Factors in Patients with Craniopharyngioma
Rachel Crowley, MD, MRCP
St. Vincent's University Hospital, Dublin, Ireland
Live Moderated Q&A and Session Closing
from ENDO 2021 on March 23, 2021 3:15 PM-4:45 PM
<< first | < prev page: of 14 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 11 12 13 14 presentations: 1 to 25 of 339